Search results
3 days ago · Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023
- Publications
For the immediate release of important public health...
- Instructions for Authors
Links with this icon indicate that you are leaving the CDC...
- Vital Signs
The CDC Vital Signs Health Topic report includes an MMWR...
- Podcasts
This episode discusses three MMWR reports. First, seven...
- Continuing Education
Tuberculosis Testing and Latent Tuberculosis Infection...
- Metrics
Links with this icon indicate that you are leaving the CDC...
- Subscribe
MMWR sends out a table of contents e-mail each week, with...
- Publications
16 hours ago · Despite high vaccination rates globally, countries are still grappling with new COVID infections, and patients diagnosed as mild dying at home during outpatient treatment. Hence, this study aim to ...
2 days ago · The idea of herd immunity works for some diseases, such as measles. But it's a harder concept to apply to illnesses like coronavirus disease 2019 (COVID-19). Read on to learn how herd immunity makes sense for some diseases but not others.
3 days ago · The risk from infection of SARS-CoV-2 has changed substantially throughout the COVID-19 pandemic with a decline of 86.03% (80.86, 89.35) and 89.67% (80.18, 93.93) in the IHR and IFR, respectively ...
4 days ago · Risk of death from COVID-19 lessens, but infection still can cause issues 3 years later. Study also shows that patients hospitalized within 30 days after infection face 29% higher death risk in 3rd year compared with those not infected. by Kristina Sauerwein • May 30, 2024. Getty Images
3 days ago · Analyses from the US Department of Veterans Affairs databases reported residual elevated risk and health burden of long COVID at 3 years in hospitalized individuals after SARS-CoV-2 infection ...
5 days ago · On September 11, 2023, the updated Moderna and Pfizer–BioNTech mRNA vaccines (i.e., 2023–2024 formulas) against coronavirus disease 2019 (Covid-19) containing the severe acute respiratory ...